Bank of America
ARRY

Bank of America’s Array Biopharma Inc ARRY Stock Holding History

Bank of America’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-772,474
Closed -$35.8M – 7737
2019
Q2 		$35.8M Sell
772,474
-78,163
-9% -$2.19M 0.01% 1377
2019
Q1 		$20.7M Buy
850,637
+80,954
+11% +$1.69M ﹤0.01% 1791
2018
Q4 		$11M Buy
769,683
+404,405
+111% +$6.13M ﹤0.01% 2209
2018
Q3 		$5.55M Buy
365,278
+17,145
+5% +$263K ﹤0.01% 3084
2018
Q2 		$5.84M Buy
348,133
+198,386
+132% +$3.16M ﹤0.01% 3002
2018
Q1 		$2.44M Sell
149,747
-261,017
-64% -$4.18M ﹤0.01% 3736
2017
Q4 		$5.26M Buy
410,764
+252,940
+160% +$2.88M ﹤0.01% 3080
2017
Q3 		$1.94M Sell
157,824
-3,471
-2% -$32.2K ﹤0.01% 4007
2017
Q2 		$1.35M Sell
161,295
-123,691
-43% -$1.01M ﹤0.01% 4217
2017
Q1 		$2.55M Buy
284,986
+247,672
+664% +$2.64M ﹤0.01% 3664
2016
Q4 		$328K Buy
37,314
+29,654
+387% +$218K ﹤0.01% 5068
2016
Q3 		$52K Sell
7,660
-14,863
-66% -$57.5K ﹤0.01% 5717
2016
Q2 		$80K Buy
22,523
+21,023
+1,402% +$68.5K ﹤0.01% 5641
2016
Q1 		$4K Sell
1,500
-60,277
-98% -$181K ﹤0.01% 6666
2015
Q4 		$261K Sell
61,777
-17,171
-22% -$78.4K ﹤0.01% 5213
2015
Q3 		$360K Sell
78,948
-26,990
-25% -$160K ﹤0.01% 5012
2015
Q2 		$764K Buy
105,938
+46,630
+79% +$344K ﹤0.01% 4343
2015
Q1 		$437K Buy
59,308
+11,971
+25% +$85.2K ﹤0.01% 4411
2014
Q4 		$224K Sell
47,337
-11,687
-20% -$46.2K ﹤0.01% 5286
2014
Q3 		$211K Sell
59,024
-64,091
-52% -$253K ﹤0.01% 5345
2014
Q2 		$561K Buy
123,115
+10,650
+9% +$44K ﹤0.01% 4500
2014
Q1 		$529K Sell
112,465
-4,915
-4% -$24.7K ﹤0.01% 4535
2013
Q4 		$588K Sell
117,380
-32,363
-22% -$176K ﹤0.01% 4618
2013
Q3 		$931K Buy
149,743
+10,509
+8% +$62.4K ﹤0.01% 4012
2013
Q2 		$632K Buy
+139,234
New +$749K ﹤0.01% 4516

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Bank of America's ARRY Position: Q3 2019 in Review

Bank of America sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 772,474 shares — an estimated $35.8M sold.

Bank of America first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $35.8M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Bank of America reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Bank of America sold 772,474 Array Biopharma Inc shares in Q3 2019, an estimated $35.8M.
  • Bank of America first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Bank of America's Array Biopharma Inc position peaked at $35.8M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Bank of America's 13F filing for Q3 2019, filed 14 Nov 2019.